IRIS Accounts Production v25.4.0.155 10858620 director 1.8.24 31.7.25 31.7.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10858620 2024-07-31 10858620 2025-07-31 10858620 2024-08-01 2025-07-31 10858620 2023-07-31 10858620 2023-08-01 2024-07-31 10858620 2024-07-31 10858620 ns15:EnglandWales 2024-08-01 2025-07-31 10858620 ns14:PoundSterling 2024-08-01 2025-07-31 10858620 ns10:Director1 2024-08-01 2025-07-31 10858620 ns10:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 10858620 ns10:SmallEntities 2024-08-01 2025-07-31 10858620 ns10:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 10858620 ns10:SmallCompaniesRegimeForDirectorsReport 2024-08-01 2025-07-31 10858620 ns10:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 10858620 ns10:FullAccounts 2024-08-01 2025-07-31 10858620 ns5:CurrentFinancialInstruments 2025-07-31 10858620 ns5:CurrentFinancialInstruments 2024-07-31 10858620 ns5:ShareCapital 2025-07-31 10858620 ns5:ShareCapital 2024-07-31 10858620 ns5:RetainedEarningsAccumulatedLosses 2025-07-31 10858620 ns5:RetainedEarningsAccumulatedLosses 2024-07-31 10858620 ns10:RegisteredOffice 2024-08-01 2025-07-31 10858620 ns5:PlantMachinery 2024-07-31 10858620 ns5:PlantMachinery 2024-08-01 2025-07-31 10858620 ns5:PlantMachinery 2025-07-31 10858620 ns5:PlantMachinery 2024-07-31 10858620 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-07-31 10858620 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-07-31

REGISTERED NUMBER: 10858620 (England and Wales)

| RM MEDICAL CONSULTING LIMITED |

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31 JULY 2025 |

RM MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 10858620)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2025

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 2 |

RM MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 10858620)

BALANCE SHEET

31 JULY 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 211 |  | 321 |  |

CURRENT ASSETS

Debtors | 5 | 53 |  | 9 |  |

Cash at bank | 53,433 |  | 16,676 |  |

53,486 |  | 16,685 |  |

CREDITORS

Amounts falling due within one year | 6 | 20,098 |  | 18,191 |  |

NET CURRENT ASSETS/(LIABILITIES) | 33,388 |  | (1,506 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 33,599 |  | (1,185 | ) |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | 33,598 |  | (1,186 | ) |

33,599 |  | (1,185 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 November 2025 and were signed by:

Dr R J Malik - Director

RM MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 10858620)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2025

1. | STATUTORY INFORMATION

| RM Medical Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 10858620

| Registered office: | 89 Babington Road

| London

| United Kingdom

| SW16 6AN

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Going Concern

| The director has a reasonable expectation that the company will continue to operate for the foreseeable future and so these financial statements are prepared on the going concern basis.

| Significant judgements and estimates

| The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. In the Director's opinion, there are no significant judgements or key sources of estimation uncertainty.

| Turnover

| Turnover is measured at the fair value of the consultancy fees received or receivable.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings |  | - 25% on straight line |  |

| Financial instruments

| The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

| Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

| Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2024 - 1 ) .

RM MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 10858620)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 JULY 2025

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 August 2024

| and 31 July 2025 | 1,939 |  |

| DEPRECIATION

| At 1 August 2024 | 1,618 |  |

| Charge for year | 110 |  |

| At 31 July 2025 | 1,728 |  |

| NET BOOK VALUE

| At 31 July 2025 | 211 |  |

| At 31 July 2024 | 321 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Other debtors | 53 |  | 9 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 9,170 |  | 1,303 |  |

| Other creditors | 10,928 |  | 16,888 |  |

20,098 |  | 18,191 |  |

7. | RELATED PARTY DISCLOSURES

| During the year, the company paid £22,050 (2024: £10,596) to the director and received repayments of £15,216 (2024: £10,177). At the balance sheet date the company owed £9,215 (2024: £16,048) to the director, and no interest was charged on this amount.